Oric Pharmaceuticals IncNASDAQ:ORIC
- LAST PRICE9.5900
- TODAY'S CHANGE (%)0.4700 (5.1535%)
- Bid / Lots9.3200/ 1
- Ask / Lots10.2000/ 1
- Open / Previous Close9.1900 / 9.1200
- Day Range
- 52 Week Range
- Volume285,786
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ORIC |
|---|---|---|
| 09:32 ET | 3660 | 9.235 |
| 09:33 ET | 113 | 9.09 |
| 09:35 ET | 2567 | 9.17 |
| 09:37 ET | 600 | 9.29 |
| 09:44 ET | 100 | 9.16 |
| 09:50 ET | 400 | 9.29 |
| 09:51 ET | 100 | 9.18 |
| 09:53 ET | 200 | 9.26 |
| 09:55 ET | 100 | 9.27 |
| 09:57 ET | 6244 | 9.445 |
| 10:02 ET | 1618 | 9.45 |
| 10:04 ET | 1851 | 9.53 |
| 10:06 ET | 1310 | 9.485 |
| 10:08 ET | 789 | 9.45 |
| 10:09 ET | 476 | 9.48 |
| 10:11 ET | 500 | 9.45 |
| 10:13 ET | 200 | 9.49 |
| 10:15 ET | 300 | 9.49 |
| 10:20 ET | 36381 | 9.505 |
| 10:22 ET | 1633 | 9.455 |
| 10:24 ET | 2094 | 9.585 |
| 10:26 ET | 100 | 9.5602 |
| 10:27 ET | 1146 | 9.55 |
| 10:29 ET | 400 | 9.47 |
| 10:31 ET | 200 | 9.39 |
| 10:33 ET | 942 | 9.3734 |
| 10:36 ET | 100 | 9.4 |
| 10:38 ET | 2135 | 9.43 |
| 10:40 ET | 200 | 9.39 |
| 10:42 ET | 100 | 9.39 |
| 10:45 ET | 400 | 9.39 |
| 10:47 ET | 400 | 9.36 |
| 10:51 ET | 790 | 9.365 |
| 10:56 ET | 100 | 9.33 |
| 10:58 ET | 300 | 9.38 |
| 11:00 ET | 200 | 9.365 |
| 11:02 ET | 700 | 9.39 |
| 11:03 ET | 203 | 9.4 |
| 11:07 ET | 200 | 9.395 |
| 11:09 ET | 100 | 9.3772 |
| 11:12 ET | 100 | 9.37 |
| 11:14 ET | 412 | 9.395 |
| 11:18 ET | 200 | 9.395 |
| 11:21 ET | 400 | 9.37 |
| 11:23 ET | 700 | 9.41 |
| 11:25 ET | 200 | 9.46 |
| 11:27 ET | 415 | 9.44 |
| 11:32 ET | 300 | 9.465 |
| 11:34 ET | 225 | 9.45 |
| 11:36 ET | 788 | 9.42 |
| 11:39 ET | 100 | 9.44 |
| 11:41 ET | 129 | 9.425 |
| 11:43 ET | 300 | 9.45 |
| 11:45 ET | 100 | 9.47 |
| 11:48 ET | 467 | 9.5 |
| 11:52 ET | 100 | 9.56 |
| 11:54 ET | 1362 | 9.535 |
| 12:01 ET | 640 | 9.47 |
| 12:03 ET | 168 | 9.51 |
| 12:06 ET | 502 | 9.54 |
| 12:08 ET | 494 | 9.52 |
| 12:14 ET | 625 | 9.53 |
| 12:15 ET | 120 | 9.53 |
| 12:17 ET | 300 | 9.53 |
| 12:19 ET | 541 | 9.545 |
| 12:21 ET | 200 | 9.57 |
| 12:24 ET | 200 | 9.59 |
| 12:30 ET | 1583 | 9.59 |
| 12:35 ET | 400 | 9.53 |
| 12:37 ET | 100 | 9.53 |
| 12:46 ET | 600 | 9.59 |
| 12:48 ET | 2087 | 9.58 |
| 12:50 ET | 126 | 9.58 |
| 12:51 ET | 100 | 9.56 |
| 12:53 ET | 100 | 9.56 |
| 12:57 ET | 200 | 9.55 |
| 01:02 ET | 200 | 9.58 |
| 01:04 ET | 1750 | 9.57 |
| 01:06 ET | 200 | 9.59 |
| 01:08 ET | 200 | 9.6099 |
| 01:11 ET | 100 | 9.62 |
| 01:13 ET | 320 | 9.625 |
| 01:20 ET | 1994 | 9.6201 |
| 01:22 ET | 420 | 9.62 |
| 01:26 ET | 120 | 9.615 |
| 01:27 ET | 400 | 9.615 |
| 01:29 ET | 100 | 9.615 |
| 01:31 ET | 1100 | 9.65 |
| 01:33 ET | 100 | 9.66 |
| 01:36 ET | 217 | 9.68 |
| 01:38 ET | 200 | 9.72 |
| 01:40 ET | 400 | 9.66 |
| 01:42 ET | 1255 | 9.66 |
| 01:44 ET | 200 | 9.6 |
| 01:45 ET | 990 | 9.5635 |
| 01:47 ET | 300 | 9.585 |
| 01:49 ET | 100 | 9.585 |
| 01:51 ET | 100 | 9.585 |
| 01:54 ET | 100 | 9.56 |
| 01:56 ET | 100 | 9.58 |
| 01:58 ET | 2001 | 9.565314 |
| 02:00 ET | 900 | 9.57 |
| 02:02 ET | 5036 | 9.52 |
| 02:03 ET | 416 | 9.525 |
| 02:07 ET | 100 | 9.505 |
| 02:09 ET | 846 | 9.51 |
| 02:12 ET | 200 | 9.51 |
| 02:14 ET | 489 | 9.52 |
| 02:18 ET | 561 | 9.5 |
| 02:20 ET | 1027 | 9.505 |
| 02:27 ET | 530 | 9.54 |
| 02:32 ET | 701 | 9.54 |
| 02:34 ET | 100 | 9.52 |
| 02:36 ET | 400 | 9.56 |
| 02:38 ET | 100 | 9.57 |
| 02:39 ET | 600 | 9.585 |
| 02:41 ET | 400 | 9.565 |
| 02:45 ET | 325 | 9.55 |
| 02:48 ET | 1192 | 9.54 |
| 02:50 ET | 813 | 9.57 |
| 02:52 ET | 600 | 9.59 |
| 02:56 ET | 100 | 9.6 |
| 02:57 ET | 400 | 9.595 |
| 03:01 ET | 100 | 9.56 |
| 03:03 ET | 100 | 9.565 |
| 03:06 ET | 1885 | 9.58 |
| 03:08 ET | 100 | 9.6 |
| 03:10 ET | 100 | 9.59 |
| 03:12 ET | 100 | 9.6 |
| 03:14 ET | 1135 | 9.61 |
| 03:17 ET | 100 | 9.62 |
| 03:21 ET | 700 | 9.63 |
| 03:26 ET | 371 | 9.65 |
| 03:28 ET | 193 | 9.64 |
| 03:30 ET | 1120 | 9.625 |
| 03:32 ET | 879 | 9.6 |
| 03:33 ET | 300 | 9.63 |
| 03:42 ET | 1222 | 9.65 |
| 03:44 ET | 940 | 9.63 |
| 03:48 ET | 319 | 9.635 |
| 03:50 ET | 1265 | 9.61 |
| 03:51 ET | 2807 | 9.605 |
| 03:53 ET | 1736 | 9.6068 |
| 03:55 ET | 3300 | 9.64 |
| 03:57 ET | 9389 | 9.64 |
| 04:00 ET | 53565 | 9.59 |
Nov 12, 2024
ORIC(R) Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones*DJ Oric Pharmaceuticals 3Q Loss/Shr 49c >ORIC, from 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 4, 2024
ORIC(R) Pharmaceuticals to Participate in Upcoming Investor Conferences, from 4:15PM ET on Monday Nov 04, 2024 by Dow Jones
4:15PM ET on Monday Nov 04, 2024 by Dow JonesDJ Oric Pharmaceuticals Price Target Maintained With a $21.00/Share by HC Wainwright & Co., from 7:04AM ET on Monday Nov 04, 2024 by Dow Jones
7:04AM ET on Monday Nov 04, 2024 by Dow Jones
Nov 1, 2024
ORIC(R) Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4), from 4:30PM ET on Friday Nov 01, 2024 by Dow Jones
4:30PM ET on Friday Nov 01, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Oric Pharmaceuticals Inc | 643.3M | -5.3x | --- |
BIOAGE Labs Inc | 661.1M | -10.5x | --- |
Tectonic Therapeutic Inc | 661.4M | -3.5x | --- |
Altimmune Inc | 597.4M | -5.6x | --- |
Oculis Holding AG | 615.7M | -7.4x | --- |
Mineralys Therapeutics Inc | 590.3M | -3.8x | --- |
Company Information
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in improving patients' lives by overcoming resistance in cancer. It is developing a pipeline of clinical and discovery stage therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology and key tumor dependencies. Its clinical-stage product candidates include ORIC-114, a brain penetrant inhibitor designed to selectively target EGFR and HER2 with high potency against exon 20 insertion mutations, being developed across multiple genetically defined cancers, ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 (PRC2) via the EED subunit, being developed for prostate cancer, and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, a key node in the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens.
Contact Information
- Headquarters
- 240 E. Grand Ave, 2nd FloorSOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-388-5600
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Richard Heyman
- President, Chief Executive Officer, Director
- Jacob Chacko
- Chief Financial Officer
- Dominic Piscitelli
- Chief Medical Officer
- Pratik Multani
- Independent Director
- Mardi Dier
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $643.3M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 70.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.11 |
EPS | $-1.81 |
Book Value | $4.08 |
P/E Ratio | -5.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
